Monitor the closing bid price of KTTA common stock closely. A reverse stock split is the most likely remedy, but its success depends on shareholder approval and market reception. If the stock fails to sustain above $1.00 by February 16, 2027, delisting is probable, which would severely impair liquidity for both the common and warrants.
Price Chart
Executive Summary
Pasithea Therapeutics received a 180-day extension from Nasdaq, moving the deadline to regain compliance with the $1.00 minimum bid price requirement from August 19, 2026 to February 16, 2027. The company remains at risk of delisting if it cannot maintain a closing bid price above $1.00 during this period, which would severely impact liquidity and institutional ownership for both the common stock (KTTA) and warrants (KTTAW).
Key Facts
- Received Nasdaq extension to February 16, 2027 to regain compliance with the $1.00 minimum bid price requirement.
- Original 180-day compliance period expired on August 19, 2026.
- Company may consider a reverse stock split to regain compliance.
- Failure to regain compliance will result in delisting notice, subject to appeal.
- Both common stock (KTTA) and warrants (KTTAW) are listed on the Nasdaq Capital Market.
Financial Impact
Delisting risk for both KTTA and KTTAW; no specific financial figures provided in filing.
Risk Factors
- Failure to regain compliance by February 16, 2027 will trigger delisting proceedings.
- Reverse stock split may not be approved or may not be sufficient to maintain compliance.
- Delisting would reduce institutional ownership and liquidity significantly.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-092672 |
| Document: 0001213900-26-092672-index-headers.html | 0001213900-26-092672 |
| Document: 0001213900-26-092672-index.html | 0001213900-26-092672 |
| Document: 0001213900-26-092672.txt | 0001213900-26-092672 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 9w ago | 8-K | $0.007400 $0.002700 | ▲ +63.51% | ▲ +63.98% | — |
May 4, 2026 25w ago | 8-K | $0.0109 $0.0109 | · 0.00% | ▼ −1.98% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers